Artificial intelligence (AI) and machine learning (ML) continues to develop how we discover and overcome challenges in drug discovery and suggests a promise to transform the path to clinic. These functionalities have the capability to expedite timelines, explore areas of drug space not previously attainable, and in turn, have the potential to reduce costs of progressing a drug through early discovery. Has this idea delivered on its hype? Join us to hear perspectives from AI thought leaders and drug hunters on how AI is actually delivering, and its potential to transform the way we navigate drug discovery.
Panel Discussion: Is the AI Revolution Empowering the Scientist?
Ready to Become
Let’s explore how Valence can
accelerate your drug discovery efforts
Oops! Something went wrong while submitting the form.